NNOX
Get informed when a big investor buys or sells
+ FollowOvervalued by 588.8% based on the discounted cash flow analysis.
| Market cap | $73.08 Million |
|---|---|
| Enterprise Value | $36.86 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.16 |
| Beta | 1.23 |
| Outstanding Shares | 69,619,000 |
| P/E Ratio | -0.92 |
|---|---|
| PEG | -11.88 |
| Price to Sales | - |
| Price to Book Ratio | 1.08 |
| Enterprise Value to Revenue | 2.54 |
| Enterprise Value to EBIT | -0.61 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 0.06 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 39.71% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.05%▼ 27.78% |
|---|---|
| Total Invested | $41,119▼ 99.90% |
| Investors Holding | 3▼ 130.00% |
No data
Nano-X Imaging Ltd operates as a medical imaging technology company. The Company offers cloud-based image analysis, online diagnosis, and billing services. Nano-X Imaging serves governments, hospitals, and clinic chains in Israel.